SIRPA and neoplasm: We weighed each tumor, as shown in Fig. 5D; the tumor weight in the radiation + dual-drug group was significantly lower than in the radiation + PD1 group (P = 0.041), validating the effectiveness of combining anti-SIRPα with RT to enhance the anti-tumor effects.